Literature DB >> 19293389

Essential role of the 90-kilodalton heat shock protein in mediating nongenomic estrogen signaling in coronary artery smooth muscle.

Guichun Han1, Handong Ma, Rajesh Chintala, David J R Fulton, Scott A Barman, Richard E White.   

Abstract

Under normal physiological conditions, estrogen is a coronary vasodilator, and this response involves production of NO from endothelial cells. In addition, estrogen also stimulates NO production in coronary artery smooth muscle (CASM); however, the molecular basis for this nongenomic effect of estrogen is unclear. The purpose of this study was to investigate a potential role for the 90-kDa heat shock protein (Hsp90) in estrogen-stimulated neuronal nitric-oxide synthase (nNOS) activity in coronary artery smooth muscle. 17Beta-estradiol produced a concentration-dependent relaxation of endothelium-denuded porcine coronary arteries in vitro, and this response was attenuated by inhibiting Hsp90 function with 1 microM geldanamycin (GA) or 100 microg/ml radicicol (RAD). These inhibitors also prevented estrogen-stimulated NO production in human CASM cells and reversed the stimulatory effect of estrogen on calcium-activated potassium (BK(Ca)) channels. These functional studies indicated a role for Hsp90 in coupling estrogen receptor activation to NOS stimulation in CASM. Furthermore, coimmunoprecipitation studies demonstrated that estrogen stimulates bimolecular interaction of immunoprecipitated nNOS with Hsp90 and that either GA or RAD could inhibit this association. Blocking estrogen receptors with ICI182780 (fulvestrant) also prevented this association. These findings indicate an essential role for Hsp90 in nongenomic estrogen signaling in CASM and further suggest that Hsp90 might represent a prospective therapeutic target to enhance estrogen-stimulated cardiovascular protection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19293389      PMCID: PMC2683768          DOI: 10.1124/jpet.108.149112

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  31 in total

1.  Codistribution of NOS and caveolin throughout peripheral vasculature and skeletal muscle of hamsters.

Authors:  S S Segal; S E Brett; W C Sessa
Journal:  Am J Physiol       Date:  1999-09

2.  Estradiol-mediated endothelial nitric oxide synthase association with heat shock protein 90 requires adenosine monophosphate-dependent protein kinase.

Authors:  Eberhard Schulz; Elad Anter; Ming-Hui Zou; John F Keaney
Journal:  Circulation       Date:  2005-06-20       Impact factor: 29.690

3.  Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. Effects on calcium sensitivity and NO release.

Authors:  K S Russell; M P Haynes; T Caulin-Glaser; J Rosneck; W C Sessa; J R Bender
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

4.  Estrogen-induced contraction of coronary arteries is mediated by superoxide generated in vascular smooth muscle.

Authors:  Richard E White; Guichun Han; Christiana Dimitropoulou; Shu Zhu; Katsuya Miyake; David Fulton; Shaylee Dave; Scott A Barman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10       Impact factor: 4.733

5.  Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men.

Authors:  R S Blumenthal; A W Heldman; J A Brinker; J R Resar; V J Coombs; S T Gloth; G Gerstenblith; S E Reis
Journal:  Am J Cardiol       Date:  1997-10-15       Impact factor: 2.778

6.  Nongenomic, endothelium-independent effects of estrogen on human coronary smooth muscle are mediated by type I (neuronal) NOS and PI3-kinase-Akt signaling.

Authors:  Guichun Han; Handong Ma; Rajesh Chintala; Katsuya Miyake; David J R Fulton; Scott A Barman; Richard E White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-03-09       Impact factor: 4.733

7.  Heat-shock protein 90 augments neuronal nitric oxide synthase activity by enhancing Ca2+/calmodulin binding.

Authors:  Y Song; J L Zweier; Y Xia
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

8.  Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism.

Authors:  R E White; D J Darkow; J L Lang
Journal:  Circ Res       Date:  1995-11       Impact factor: 17.367

9.  Neuronal nitric-oxide synthase is regulated by the Hsp90-based chaperone system in vivo.

Authors:  A T Bender; A M Silverstein; D R Demady; K C Kanelakis; S Noguchi; W B Pratt; Y Osawa
Journal:  J Biol Chem       Date:  1999-01-15       Impact factor: 5.157

10.  K+ currents in human coronary artery vascular smooth muscle cells.

Authors:  M Gollasch; C Ried; R Bychkov; F C Luft; H Haller
Journal:  Circ Res       Date:  1996-04       Impact factor: 17.367

View more
  16 in total

1.  Ovine HSP90AA1 gene promoter: functional study and epigenetic modifications.

Authors:  Judit Salces-Ortiz; Carmen González; Alfonso Bolado-Carrancio; Jose Carlos Rodríguez-Rey; Jorge H Calvo; Rubén Muñoz; M Magdalena Serrano
Journal:  Cell Stress Chaperones       Date:  2015-08-08       Impact factor: 3.667

2.  Estradiol regulates human QT-interval: acceleration of cardiac repolarization by enhanced KCNH2 membrane trafficking.

Authors:  Lars Anneken; Stefan Baumann; Patrick Vigneault; Peter Biliczki; Corinna Friedrich; Ling Xiao; Zenawit Girmatsion; Ina Takac; Ralf P Brandes; Stefan Kissler; Inka Wiegratz; Sven Zumhagen; Birgit Stallmeyer; Stefan H Hohnloser; Thomas Klingenheben; Eric Schulze-Bahr; Stanley Nattel; Joachim R Ehrlich
Journal:  Eur Heart J       Date:  2015-08-12       Impact factor: 29.983

3.  β3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+ pump in hyperglycemia induced by insulin receptor blockade.

Authors:  Keyvan Karimi Galougahi; Chia-Chi Liu; Alvaro Garcia; Natasha A Fry; Elisha J Hamilton; Gemma A Figtree; Helge H Rasmussen
Journal:  Am J Physiol Cell Physiol       Date:  2015-06-10       Impact factor: 4.249

4.  Modulation of heme/substrate binding cleft of neuronal nitric-oxide synthase (nNOS) regulates binding of Hsp90 and Hsp70 proteins and nNOS ubiquitination.

Authors:  Hwei-Ming Peng; Yoshihiro Morishima; William B Pratt; Yoichi Osawa
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

5.  Testosterone-induced relaxation of coronary arteries: activation of BKCa channels via the cGMP-dependent protein kinase.

Authors:  Viju Deenadayalu; Yashoda Puttabyatappa; Alexander T Liu; John N Stallone; Richard E White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-11       Impact factor: 4.733

6.  HDAC6 regulates glucocorticoid receptor signaling in serotonin pathways with critical impact on stress resilience.

Authors:  Julie Espallergues; Sarah L Teegarden; Avin Veerakumar; Janette Boulden; Collin Challis; Jeanine Jochems; Michael Chan; Tess Petersen; Evan Deneris; Patrick Matthias; Chang-Gyu Hahn; Irwin Lucki; Sheryl G Beck; Olivier Berton
Journal:  J Neurosci       Date:  2012-03-28       Impact factor: 6.167

7.  Estrogen signaling in microvascular arteries: parturition reduces vasodilation by reducing 17β-estradiol and nNOS.

Authors:  Crista R Royal; Handong Ma; Richard Walker; Richard E White
Journal:  Steroids       Date:  2011-03-31       Impact factor: 2.668

8.  Activation of G protein-coupled estrogen receptor induces endothelium-independent relaxation of coronary artery smooth muscle.

Authors:  Xuan Yu; Handong Ma; Scott A Barman; Alexander T Liu; Minga Sellers; John N Stallone; Eric R Prossnitz; Richard E White; Guichun Han
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-26       Impact factor: 4.310

9.  Modulation of α(2C) adrenergic receptor temperature-sensitive trafficking by HSP90.

Authors:  Catalin M Filipeanu; René de Vries; A H Jan Danser; Daniel R Kapusta
Journal:  Biochim Biophys Acta       Date:  2010-12-09

Review 10.  G-protein-coupled estrogen receptor as a new therapeutic target for treating coronary artery disease.

Authors:  Guichun Han; Richard E White
Journal:  World J Cardiol       Date:  2014-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.